<DOC>
	<DOC>NCT02580578</DOC>
	<brief_summary>This study will characterize the treatments and outcomes associated with different uterine fibroid treatments in Canada, to understand patients' preferences and satisfaction with different medical and procedural interventions. The study will also assess the effectiveness of ulipristal acetate (FibristalÂ®) in controlling bleeding, reducing fibroid volume and symptoms, and improvement in patient's quality of life.</brief_summary>
	<brief_title>A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<criteria>Premenopausal adult women with confirmed diagnosis and symptoms associated with uterine fibroids who are initiating treatment. Significant pelvic pathology not associated with uterine fibroids.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>